![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Chen ZJ Le HB Zhang YK Qian LY Li WD
Publisher: Field House Publishing
ISSN: 0300-0605
Source: The Journal of International Medical Research, Vol.37, Iss.2, 2009-03, pp. : 551-556
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pemetrexed for the treatment of non-small cell lung cancer
By Genova Carlo
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Economics of Treatments for Non-Small Cell Lung Cancer
By Chouaid Christos Atsou Kukovi
PharmacoEconomics, Vol. 27, Iss. 2, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gemcitabine in non-small cell lung cancer
By Cappuzzo Federico Crinò Lucio
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. :